Prescribing statins

British Journal of Clinical Pharmacology

Volumn 60, Issue 5, 2005, Pages 457-458

  Aronson, J K ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; FLUINDOSTATIN; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PRESCRIPTION; PRIORITY JOURNAL; STROKE;

CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA;

EID: 27444434011     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02521.x     Document Type: Editorial

References (14)

1. Aronson JK. Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions. J Eval Clin Pract 2005; 11: 195-208.
2. Aronson JK. Rational prescribing, appropriate prescribing. Br J Clin Pharmacol 2004; 57: 229-30.
3. Aronson JK. Over-the-counter medicines. Br J Clin Pharmacol 2004; 58: 231-4.
4. Olsson AG, Molgaard J, Von Schenk H. Synvinolin in hypercholesterolaemia. Lancet 1986; 2: 390-1.
5. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. Br Med J 2003; 326: 1419-22.
6. Various authors. Rapid responses to Wald & Law. Available from http://bmj.bmjjournals.com/cgi/eletters/326/7404/1419
7. Fahey T, Brindle P, Ebrahim S. The polypill and cardiovascular disease. Br Med J 2005; 330: 1035-6.
8. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet Online doi: 10.1016/S0140-6736(05)67394-1.
9. BBC News. World Edition, 26 September 2005. Statins 'could benefit many more'. Available from http://news.bbc.co.uk/2/hi/health/4282194.stm
10. Walley T, Folino-Gallo P, Stephens P, Van Ganse E, on behalf of the EuroMedStat Group. Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. Br J Clin Pharmacol 2005; 60: 543-551.
11. Mantel-Teeuwisse AK, Verschuren WM, Klungel OH, De Boer A, Kromhout D. Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands. Br J Clin Pharmacol 2004; 58: 310-16.
12. Mantel-Teeuwisse AK, Klungel OH, Schalekamp T, Verschuren WM, Porsius AJ, De Boer A. Suboptimal choices and dosing of statins at start of therapy. Br J Clin Pharmacol 2005; 60: 83-9.
13. Thomsen RW, Johnsen SP, Olesen AV, Mortensen JT, Bøggild H, Olsen J, Sørensen HJT. Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 2005; 60: 534-542.
14. Dybdahl T, Andersen M, Kragstrup J, Kristiansen IS, Sondergaard J. General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study. Br J Clin Pharmacol 2005; 60: 526-533.